BackIntegrated BioPharma Overview

Integrated BioPharma Receivables

Integrated BioPharma's receivables is $3.7M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$3.72M
↓ 6.60% YoYΔ $-263000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Integrated BioPharma Receivables History

Loading

Integrated BioPharma vs. peers: Receivables Comparison

Loading

Integrated BioPharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Integrated BioPharma (INBP) FAQ

Integrated BioPharma (INBP) currently reports a receivables of $3.7M as of September 2026. That compares with $4M in the prior-year period — down 6.6% year over year. Use the charts on this page to explore Integrated BioPharma's receivables history and peer comparisons.

Integrated BioPharma's receivables decreased from $4M to $3.7M — a 6.6% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Integrated BioPharma reported $3.7M in receivables as of September 2026. That compares with $4M in the prior-year period — down 6.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $3.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Integrated BioPharma, and consider following INBP for alerts when major investors trade the stock.

Questions & Answers